- Lexicon Pharmaceuticals (NASDAQ:LXRX): Q2 EPS of -$0.05 in-line.
- Revenue of $0.7M (+233.3% Y/Y) beats by $0.58M.
- Press Release
Lexicon Pharmaceuticals EPS in-line, beats on revenue
Recommended For You
More Trending News
About LXRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| LXRX | - | - |
| Lexicon Pharmaceuticals, Inc. | ||